Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer (Q47631180)

4 February 2018

title

Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer (English)

1 reference

4 February 2018

1 reference

Joellen M Schildkraut

8

object named as

Joellen Schildkraut

1 reference

4 February 2018

10

Andrew Berchuck

1 reference

4 February 2018

author name string

Robert M Wenham

1

1 reference

4 February 2018

Brian Calingaert

2

1 reference

4 February 2018

Shazia Ali

3

1 reference

4 February 2018

Kia McClean

4

1 reference

4 February 2018

Regina Whitaker

5

1 reference

4 February 2018

Rex Bentley

6

1 reference

4 February 2018

Johnathan M Lancaster

7

1 reference

4 February 2018

Jeffrey Marks

9

1 reference

4 February 2018

publication date

1 September 2003

1 reference

4 February 2018

published in

Reproductive Sciences

1 reference

4 February 2018

volume

10

1 reference

4 February 2018

issue

6

1 reference

4 February 2018

page(s)

381-387

1 reference

4 February 2018

Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

Changing views of the role of matrix metalloproteinases in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

Predicting the clinical status of human breast cancer by using gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

Molecular determinants of ovarian cancer plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

7 January 2021

Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

7 January 2021

CYP17 promotor polymorphism and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

7 January 2021

p53 polymorphism in ovarian and bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

7 January 2021

p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

7 January 2021

Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1071-55760300141-2

7 January 2021

10.1016/S1071-55760300141-2

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

12969782

1 reference

4 February 2018